Hap Trading, LLC Biogen Inc. Put Options Transaction History

Hap Trading, LLC

$840 Billion
Q2 2024

Put Options

23 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2023 May 12, 2023	SELL	$256.56 - $292.34 $6.59 Million - $7.51 Million	-25,700 Reduced 64.74%	14,000 $24,000
Q4 2022 Feb 14, 2023	BUY	$252.44 - $306.72 $3.69 Million - $4.48 Million	14,600 Added 58.17%	39,700 $286,000
Q3 2022 Nov 14, 2022	BUY	$194.69 - $268.46 $1.13 Million - $1.56 Million	5,800 Added 30.05%	25,100 $479,000
Q2 2022 Aug 12, 2022	BUY	$187.54 - $223.02 $431,342 - $512,946	2,300 Added 13.53%	19,300 $1.12 Million
Q1 2022 May 12, 2022	SELL	$193.77 - $244.14 $3.26 Million - $4.1 Million	-16,800 Reduced 49.7%	17,000 $1.03 Million
Q4 2021 Feb 14, 2022	BUY	$223.92 - $287.77 $134,352 - $172,662	600 Added 1.81%	33,800 $1.05 Million
Q3 2021 Nov 10, 2021	SELL	$282.99 - $369.05 $1.81 Million - $2.36 Million	-6,400 Reduced 16.16%	33,200 $769,000
Q2 2021 Aug 11, 2021	SELL	$259.0 - $414.71 $129,500 - $207,355	-500 Reduced 1.25%	39,600 $495,000
Q1 2021 May 14, 2021	SELL	$242.95 - $284.63 $4.2 Million - $4.92 Million	-17,300 Reduced 30.14%	40,100 $583,000
Q4 2020 Feb 16, 2021	BUY	$236.26 - $355.63 $9.69 Million - $14.6 Million	41,000 Added 250.0%	57,400 $1.52 Million
Q3 2020 Nov 13, 2020	SELL	$264.77 - $305.71 $370,678 - $427,994	-1,400 Reduced 7.87%	16,400 $311,000
Q2 2020 Aug 10, 2020	BUY	$258.66 - $342.55 $181,062 - $239,785	700 Added 4.09%	17,800 $395,000
Q1 2020 May 08, 2020	SELL	$268.85 - $341.04 $53,770 - $68,208	-200 Reduced 1.16%	17,100 $299,000
Q4 2019 Feb 11, 2020	SELL	$220.06 - $304.07 $16.7 Million - $23 Million	-75,800 Reduced 81.42%	17,300 $286,000
Q3 2019 Nov 12, 2019	BUY	$217.44 - $243.88 $17.4 Million - $19.5 Million	80,100 Added 616.15%	93,100 $291,000
Q2 2019 Aug 14, 2019	BUY	$219.29 - $241.72 $679,799 - $749,332	3,100 Added 31.31%	13,000 $187,000
Q1 2019 May 10, 2019	BUY	$216.71 - $338.96 $2.15 Million - $3.36 Million	9,900 New	9,900 $252,000
Q4 2018 Feb 12, 2019	SELL	$278.5 - $352.75 $3.51 Million - $4.44 Million	-12,600 Closed	0 $0
Q3 2018 Nov 09, 2018	BUY	$293.51 - $383.83 $3.7 Million - $4.84 Million	12,600 New	12,600 $52,000
Q2 2018 Aug 13, 2018	SELL	$257.52 - $306.91 $2.03 Million - $2.42 Million	-7,900 Closed	0 $0
Q1 2018 May 11, 2018	SELL	$260.13 - $367.91 $2.5 Million - $3.53 Million	-9,600 Reduced 54.86%	7,900 $239,000
Q4 2017 Feb 09, 2018	BUY	$307.64 - $344.58 $892,156 - $999,282	2,900 Added 19.86%	17,500 $165,000
Q3 2017 Nov 08, 2017	BUY	$281.15 - $329.69 $4.1 Million - $4.81 Million	14,600	14,600 $138,000

Others Institutions Holding BIIB

# of Institutions

1,050

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

Vanguard Group Inc Valley Forge, PA

16.6M
Shares

$3.13 Billion
0.08% of portfolio
Primecap Management CO Pasadena, CA

16.3M
Shares

$3.08 Billion
2.78% of portfolio
Black Rock Inc. New York, NY

14.5M
Shares

$2.74 Billion
0.08% of portfolio
State Street Corp Boston, MA

7.1M
Shares

$1.34 Billion
0.07% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

5.68M
Shares

$1.07 Billion
0.83% of portfolio

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $27.2B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hap Trading, LLC with notifications on news.

Account